<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="4-part\PMC7179685\results\search\tropicalVirus\results.xml">
  <result pre="Original Research Iminosugars With Endoplasmic Reticulum α-Glucosidase Inhibitor Activity Inhibit" exact="ZIKV" post="Replication and Reverse Cytopathogenicity in vitro BhushanGitanjaliLimLevinaBirdIanChotheShubhada K.NisslyRuth H.KuchipudiSuresh"/>
  <result pre="is permitted which does not comply with these terms. Abstract" exact="Zika" post="virus (ZIKV), a vector-borne virus of the family Flaviviridae,"/>
  <result pre="μM. Iminosugar treatment of Vero or CHME3 cells prior to" exact="ZIKV" post="infection resulted in significant inhibition of ZIKV replication over"/>
  <result pre="cells prior to ZIKV infection resulted in significant inhibition of" exact="ZIKV" post="replication over 48 h. Reduction in ZIKV replication in"/>
  <result pre="significant inhibition of ZIKV replication over 48 h. Reduction in" exact="ZIKV" post="replication in iminosugar-treated cells was not associated with any"/>
  <result pre="exhibited a substantial reduction of necrosis at 72 hpi following" exact="ZIKV" post="infection. In summary, iminosugars with ER-AGI activity inhibit ZIKV"/>
  <result pre="following ZIKV infection. In summary, iminosugars with ER-AGI activity inhibit" exact="ZIKV" post="replication and significantly reduce necrosis without altering the antiviral"/>
  <result pre="anti-ZIKV antiviral agents and such warrant further in vivo studies." exact="Zika" post="virus antiviral iminosugar ER-AGI castanospermine celgosivir DNJ Funding College"/>
  <result pre="Pennsylvania State University10.13039/100009791 fig-count: table-count: equation-count: ref-count: page-count: word-count: Introduction" exact="Zika" post="virus is an icosahedral, enveloped RNA virus of the"/>
  <result pre="mosquito species are the two main insect vectors that transmit" exact="ZIKV" post="(Vorou, 2016). Human to human transmission through bodily fluids"/>
  <result pre="and the maternal-fetal route has also been established (WHO, 2016)." exact="Zika" post="virus (ZIKV) has recently garnered global attention following its"/>
  <result pre="a public health emergency due to the increased association of" exact="ZIKV" post="infections with fetal abnormalities, autoimmune disease, and neurological disorders."/>
  <result pre="ZIKV infections with fetal abnormalities, autoimmune disease, and neurological disorders." exact="ZIKV" post="has been relatively uninvestigated since its initial discovery in"/>
  <result pre="public attention in 2013 when several humans were infected with" exact="ZIKV" post="in French Polynesia (Cao-Lormeau et al., 2014; Oehler et"/>
  <result pre="2014; Oehler et al., 2014). Until this point, symptoms of" exact="ZIKV" post="infection were mild, including fever, rash, and malaise. Since"/>
  <result pre="Since its emergence in the Pacific islands and the Americas," exact="ZIKV" post="has been associated with increased infection rates, neurological pathologies"/>
  <result pre="microcephaly in infants (Musso and Gubler, 2016). By phylogenetic analysis," exact="ZIKV" post="isolates cluster into two lineages, namely African and Asian"/>
  <result pre="lineages, namely African and Asian (Haddow et al., 2012). Epidemic" exact="ZIKV" post="strains from French Polynesia and the Americas cluster are"/>
  <result pre="the Americas cluster are included in the Asian lineage of" exact="ZIKV" post="(Lanciotti et al., 2016). African strains have been shown"/>
  <result pre="al., 2018). One of the most alarming outcomes associated with" exact="ZIKV" post="infection during pregnancy is microcephaly (Petersen et al., 2016)."/>
  <result pre="are born with small heads due to abnormal brain development." exact="ZIKV" post="RNA has been found in amniotic fluid as well"/>
  <result pre="Hofbauer macrophages and trophoblasts, fetal brain cells are targets of" exact="ZIKV" post="infection (Kendra et al., 2016). In vitro studies have"/>
  <result pre="cells, astrocytes, microglia, and oligodendrocyte precursor cells are vulnerable to" exact="ZIKV" post="infection (Tang et al., 2016; Retallack et al., 2016)."/>
  <result pre="al., 2016; Retallack et al., 2016). An ability to limit" exact="ZIKV" post="replication in mothers and/or reduce ZIKV infection of fetal"/>
  <result pre="An ability to limit ZIKV replication in mothers and/or reduce" exact="ZIKV" post="infection of fetal brain cells may prevent microcephaly. Current"/>
  <result pre="prevent microcephaly. Current strategies for the prevention and control of" exact="ZIKV" post="involves vector control and symptomatic therapy. Despite the considerable"/>
  <result pre="currently, there are no FDA-approved drugs to prevent and treat" exact="ZIKV" post="infection. A primary focus of current ZIKV antiviral research"/>
  <result pre="prevent and treat ZIKV infection. A primary focus of current" exact="ZIKV" post="antiviral research is directed at targeting virus entry and"/>
  <result pre="directed at targeting virus entry and the virus replication pathways." exact="ZIKV" post="entry is mediated by a set of proposed receptors"/>
  <result pre="unclear whether there are additional and/or alternative receptors that facilitate" exact="ZIKV" post="entry. A significant downside of virus-directed antiviral agents in"/>
  <result pre="and host-directed antivirals could be a more practical approach for" exact="ZIKV" post="antiviral therapy. A promising avenue for effective anti-flaviviral therapeutics"/>
  <result pre="vaccinia virus (Sadat et al., 2014; Alonzi et al., 2017)." exact="Zika" post="virus, like other flaviviruses, has three N-glycosylated proteins, precursor"/>
  <result pre="NS1, that are substrates for the ER α-glucosidase enzymes during" exact="ZIKV" post="replication (Wu et al., 2002). ZIKV replication and viral"/>
  <result pre="ER α-glucosidase enzymes during ZIKV replication (Wu et al., 2002)." exact="ZIKV" post="replication and viral RNA synthesis occurs on an extended"/>
  <result pre="an extended network of modified endoplasmic reticulum (ER) membranes. The" exact="ZIKV" post="capsid protein binds to viral RNA during the process"/>
  <result pre="recent report has examined the role of these compounds in" exact="ZIKV" post="infection (Ma et al., 2018). In these studies, hepatocellular"/>
  <result pre="of α-glucosidases I or II supported a reduced level of" exact="ZIKV" post="viral replication compared with wild-type cells (Ma et al.,"/>
  <result pre="in comparison to ER α-glucosidase II (Ma et al., 2018)." exact="ZIKV" post="viral replication was reduced in embryonic kidney cells when"/>
  <result pre="To date, no investigations of the use of iminosugars against" exact="ZIKV" post="in clinically relevant cell types, such as human brain"/>
  <result pre="CHME3 cells. Iminosugar treatment resulted in a significant reduction in" exact="ZIKV" post="replication and cell necrosis. Notably, iminosugar treatment did not"/>
  <result pre="iminosugar treatment did not alter apoptosis and antiviral response of" exact="ZIKV" post="infected cells. Materials and Methods Viruses, Cells, and Compounds"/>
  <result pre="cells. Materials and Methods Viruses, Cells, and Compounds Two human" exact="ZIKV" post="strains, namely PRVABCB59 (Human/2015/Puerto Rico), IBH30656 (Human/1968/Nigeria) and one"/>
  <result pre="strains, namely PRVABCB59 (Human/2015/Puerto Rico), IBH30656 (Human/1968/Nigeria) and one mosquito" exact="ZIKV" post="strain MEX 2-81 (Mosquito/2016/Mexico) obtained from BEI Resources were"/>
  <result pre="pretreated with iminosugars for 2 h and then infected with" exact="ZIKV" post="according to the plate layout shown in Supplementary Figure"/>
  <result pre="Cells treated with iminosugars or vehicle control were infected with" exact="ZIKV" post="strain PRVABC59, IBH30656 or MEX 2-81 at a multiplicity"/>
  <result pre="Previous studies have shown that ER α-glucosidase inhibitor, Celgosivir prevents" exact="DENV" post="secretion in primary human macrophages with an EC50 of"/>
  <result pre="al., 2004; Sung et al., 2016). Virus Yield Reduction Assay" exact="Zika" post="virus yield reduction following treatment with iminosugars was assessed"/>
  <result pre="Deep Well Magnetic Particle Processor (Applied Biosystems). The amount of" exact="ZIKV" post="genomic RNA was measured by qRT-PCR using SuperScript® III"/>
  <result pre="then 55°C for 30 s (Goebel et al., 2016). The" exact="ZIKV" post="copy numbers were quantified using a standard curve generated"/>
  <result pre="a standard curve generated with serial dilutions of positive control" exact="ZIKV" post="RNA standards derived from ZIKV with known TCID50 value."/>
  <result pre="serial dilutions of positive control ZIKV RNA standards derived from" exact="ZIKV" post="with known TCID50 value. Cell culture supernatants were titrated"/>
  <result pre="μM was selected for targeted investigation of iminosugar effects on" exact="ZIKV" post="infection. FIGURE 1 Castanospermine significantly inhibits Zika virus (ZIKV)"/>
  <result pre="iminosugar effects on ZIKV infection. FIGURE 1 Castanospermine significantly inhibits" exact="Zika" post="virus (ZIKV) replication in Vero and CHME3 cells without"/>
  <result pre="from Vero cells (C,E) and CHME3 cells (D,F) infected with" exact="ZIKV" post="PRVABC59 at MOI of 0.5 or 5 with and"/>
  <result pre="without 1 μM castanospermine treatment were harvested at 48 hpi." exact="ZIKV" post="RNA levels were determined by qRT-PCR assay (C,D). Infectious"/>
  <result pre="ZIKV RNA levels were determined by qRT-PCR assay (C,D). Infectious" exact="ZIKV" post="titration was determined by TCID50 assay (E,F). Data represent"/>
  <result pre="Error bars represent standard deviation. FIGURE 2 Celgosivir significantly inhibits" exact="Zika" post="virus (ZIKV) replication in Vero and CHME3 cells without"/>
  <result pre="from Vero cells (C,E) and CHME3 cells (D,F) infected with" exact="ZIKV" post="PRVABC59 at MOI of 0.5 or 5 with and"/>
  <result pre="without 1 μM celgosivir treatment were harvested at 48 hpi." exact="ZIKV" post="RNA levels were determined by qRT-PCR assay (C,D). Data"/>
  <result pre="(C,D). Data represent mean values of four biological replicates. Infectious" exact="ZIKV" post="titration was determined by TCID50 assay (E,F). Error bars"/>
  <result pre="bars represent standard deviation. FIGURE 3 Deoxynojirimycin (DNJ) significantly inhibits" exact="Zika" post="virus (ZIKV) replication in Vero and CHME3 cells without"/>
  <result pre="from Vero cells (C,E) and CHME3 cells (D,F) infected with" exact="ZIKV" post="PRVABC59 at MOI of 0.5 or 5 with and"/>
  <result pre="without 1 μM DNJ treatment were harvested at 48 hpi." exact="ZIKV" post="RNA levels were determined by qRT-PCR assay (C,D). Infectious"/>
  <result pre="ZIKV RNA levels were determined by qRT-PCR assay (C,D). Infectious" exact="ZIKV" post="titration was determined by TCID50 assay (E,F). Data represent"/>
  <result pre="(E,F). Data represent mean values of four biological replicates. Infectious" exact="ZIKV" post="titration was determined by TCID50 assay (E,F). Error bars"/>
  <result pre="(E,F). Error bars represent standard deviation. Iminosugar Treatment Significantly Inhibits" exact="ZIKV" post="PRVABC59 Replication in Vero and CHME3 Cells To evaluate"/>
  <result pre="CHME3 Cells To evaluate the ability of iminosugars to inhibit" exact="ZIKV" post="replication, we compared viral RNA and infectious virus in"/>
  <result pre="with and without iminosugar treatment. Because the Asian lineage of" exact="ZIKV" post="is responsible for the recent epidemics in the Americas"/>
  <result pre="recent epidemics in the Americas with increased morbidity compared with" exact="ZIKV" post="of the African lineage, we first investigated infection with"/>
  <result pre="in Puerto Rico. Significant reductions (p ≤ 0.0318) of PRVABC59" exact="ZIKV" post="RNA compared with vehicle control were observed in supernatants"/>
  <result pre="a statistically significant reduction (p ≤ 0.0433) in infectious PRVABC59" exact="ZIKV" post="titers as measured by TCID50 quantification was observed in"/>
  <result pre="and CHME3 cells (Figures 1F, 2F, 3F) infected with PRVABC59" exact="ZIKV" post="at both MOI 0.5 and MOI 5, with the"/>
  <result pre="cells infected at MOI 0.5 which was not statistically significant." exact="ZIKV" post="PRVABC59 Infection Increases Antiviral Gene Expression in CHME3 Cells"/>
  <result pre="Gene Expression in CHME3 Cells The antiviral gene response to" exact="ZIKV" post="in human microglial cells is not fully characterized. To"/>
  <result pre="RIG-I, MX1, IRF7, IFNβ, and ISG15 following infection with PRVABC59" exact="ZIKV" post="(Figure 4). All genes were slightly downregulated at 24"/>
  <result pre="does not inhibit antiviral response in CHME3 cells infected with" exact="Zika" post="virus (ZIKV). Relative mRNA expression profiles of MDA5 (A),"/>
  <result pre="IFNβ (E), and ISG15 (F) of CHME3 cells infected with" exact="ZIKV" post="PRVABC59 at 24, 48, and 72 hpi. Data points"/>
  <result pre="mock-infected cells at 72 hpi. Celgosivir Treatment Protects Cells From" exact="ZIKV" post="Cytopathogenicity Having demonstrated that the inhibition of PRVABC59 ZIKV"/>
  <result pre="From ZIKV Cytopathogenicity Having demonstrated that the inhibition of PRVABC59" exact="ZIKV" post="by iminosugar celgosivir was not due to altered cellular"/>
  <result pre="their ability to reduce ZIKV-induced cell death induced by PRVABC59" exact="ZIKV" post="in both Vero and CHME3 cells. Across all concentrations,"/>
  <result pre="endoplasmic-reticulum α-glucosidase inhibitor treatment restores cell viability following infection with" exact="Zika" post="virus (ZIKV) in Vero and CHME3 cells. Cell viability"/>
  <result pre="or vehicle-treated Vero (A,C,E) or CHME3 (B,D,F) cells infected with" exact="ZIKV" post="strain PRVABC59. Absorbance was measured at 490 nm. Data"/>
  <result pre="showing standard deviation. Celgosivir Treatment Does Not Affect Apoptosis in" exact="ZIKV" post="Infected CHME3 Cells Zika virus has been shown to"/>
  <result pre="Treatment Does Not Affect Apoptosis in ZIKV Infected CHME3 Cells" exact="Zika" post="virus has been shown to induce apoptosis in different"/>
  <result pre="2017). Apoptosis is a mechanism the cells use to limit" exact="ZIKV" post="spread. Levels of activated caspases 3 and 7 were"/>
  <result pre="the apoptosis response in PRVABC59 ZIKV-infected cells. CHME3 infection with" exact="ZIKV" post="strain PRVABC59 at MOI 1 substantially increased activated caspases"/>
  <result pre="7 in comparison to untreated CHME3 cells infected with PRVABC59" exact="ZIKV" post="at both 48 and 72 hpi (Figure 6). FIGURE"/>
  <result pre="alter activated caspase 3/7 levels in CHME3 cells infected with" exact="Zika" post="virus (ZIKV). Luminescence measurements of activated caspase 3/7 from"/>
  <result pre="cells 48 (A) and 72 (B) hours following infection with" exact="ZIKV" post="PRVABC59 with and without celgosivir. Data points represents mean"/>
  <result pre="deviation. Celgosivir Treatment Is Associated With Lower Cell Necrosis After" exact="ZIKV" post="Infection Zika virus has been shown to cause necrosis"/>
  <result pre="Treatment Is Associated With Lower Cell Necrosis After ZIKV Infection" exact="Zika" post="virus has been shown to cause necrosis in human"/>
  <result pre="the brains of newborn babies who are congenitally infected with" exact="ZIKV" post="(Roosecelis Brasil Martines et al., 2016). The effect of"/>
  <result pre="iminosugar use could reduce ZIKV-induced necrosis. CHME3 infection with PRVABC59" exact="ZIKV" post="alone substantially increased LDH levels at 48 and 72"/>
  <result pre="7 Celgosivir rescues CHME3 cells from necrosis following infection with" exact="Zika" post="virus (ZIKV). Absorbance measurements of LDH levels from CHME3"/>
  <result pre="cells 48 (A) and 72 (B) hours following infection with" exact="ZIKV" post="PRVABC59 at MOI of 1 with and without celgosivir."/>
  <result pre="&amp;lt; 0.01, ***p &amp;lt; 0.001. Iminosugars Inhibit Replication of Multiple" exact="ZIKV" post="Strains Iminosugars were further evaluated for antiviral activity against"/>
  <result pre="Iminosugars were further evaluated for antiviral activity against two other" exact="ZIKV" post="isolates in Vero cells by measuring reduction of cytopathic"/>
  <result pre="cells by measuring reduction of cytopathic effect (cell death) after" exact="ZIKV" post="infection. An African lineage strain isolated from a human"/>
  <result pre="with iminosugar, ZIKV-induced cell death was reduced regardless of the" exact="ZIKV" post="strain or cell type used (Figure 8). Vero cells"/>
  <result pre="Iminosugar endoplasmic-reticulum α-glucosidase inhibitor treatment restores cell viability following infection" exact="Zika" post="virus (ZIKV) strains IBH30656 or MEX 2-81 in Vero"/>
  <result pre="and DNJ- (E,F) treated or vehicle-treated Vero cells infected with" exact="ZIKV" post="strain IBH30656 (A,C,E) or MEX 2-81 (B,D,F). Absorbance was"/>
  <result pre="four biological replicates, with error bars showing standard deviation. Discussion" exact="Zika" post="virus continues to spread throughout the world and remains"/>
  <result pre="an urgent need to investigate and evaluate antiviral therapies for" exact="ZIKV" post="infection. In this study, we evaluated the ability of"/>
  <result pre="α-glucosidase inhibitor (ER-AGI) activity with different chemical structures to inhibit" exact="ZIKV" post="replication both in a cell line commonly used to"/>
  <result pre="replication both in a cell line commonly used to propagate" exact="ZIKV" post="(Vero cells) and in a clinically relevant human microglial"/>
  <result pre="This study provides evidence of effectiveness of iminosugars to inhibit" exact="ZIKV" post="in cells from the brain, rescuing cells from ZIKV-induced"/>
  <result pre="death while maintaining cellular antiviral response. We found that following" exact="ZIKV" post="infection in both Vero and CHME3 cells infected at"/>
  <result pre="recent study reported the first use of iminosugar therapy against" exact="ZIKV" post="wherein the iminosugar IHVR-19029 decreased ZIKV RNA production following"/>
  <result pre="of iminosugar therapy against ZIKV wherein the iminosugar IHVR-19029 decreased" exact="ZIKV" post="RNA production following HEK293 embryonic kidney cells infected at"/>
  <result pre="half maximal effective concentration of celgosivir was similar against all" exact="DENV" post="serotypes (DENV 1-4) in THP-1 human monocytes (Rathore et"/>
  <result pre="viral spread and virion secretion of all four serotypes of" exact="DENV" post="(Whitby et al., 2005). Although the iminosugars we tested"/>
  <result pre="al., 2005). Although the iminosugars we tested demonstrated effectiveness against" exact="ZIKV" post="starting at very low concentrations, castanospermine, DNJ and celgosivir"/>
  <result pre="an attractive feature of these iminosugars for potential use against" exact="ZIKV" post="to prevent damage to the developing brain. Iminosugars are"/>
  <result pre="investigate the mechanism underlying the ability of iminosugars to inhibit" exact="ZIKV" post="replication, our results suggest that the reduction in ZIKV-induced"/>
  <result pre="infectious. It is well-known that the infection of cells with" exact="ZIKV" post="induces the upregulation of antiviral genes (Carlin et al.,"/>
  <result pre="al., 2018). Our study also found that in CHME3 cells" exact="ZIKV" post="infection resulted in upregulation of type I interferon (IFNβ),"/>
  <result pre="affected by addition of celgosivir, despite celgosivir reducing magnitude of" exact="ZIKV" post="infection. Since the results of misfolded viral proteins includes"/>
  <result pre="in neural progenitor cells at 24 h after infection with" exact="ZIKV" post="(Souza et al., 2016). Notably, there was no statistically"/>
  <result pre="levels of caspase 3/7 between celgosivir- and vehicle-treated cells after" exact="ZIKV" post="infection. The significance of apoptosis of microglia is unclear,"/>
  <result pre="in developing brain (Reemst et al., 2016), that supported persistent" exact="ZIKV" post="infection of both African and Asian lineage ZIKV were"/>
  <result pre="supported persistent ZIKV infection of both African and Asian lineage" exact="ZIKV" post="were relatively resistant to virus-induced apoptosis, suggesting that lack"/>
  <result pre="suggesting that lack of apoptosis could lead to persistence of" exact="ZIKV" post="infection in developing brain cells and lead to ZIKV-induced"/>
  <result pre="to the leakage of cellular contents. It is clear that" exact="ZIKV" post="can induce high levels of cell death (Costa et"/>
  <result pre="development (Gomez Perdiguero et al., 2015). Our data showed that" exact="ZIKV" post="infection of CHME3 microglial cells results in substantial necrosis"/>
  <result pre="found that celgosivir was able to decrease necrosis induced by" exact="ZIKV" post="at 72 hpi, which could limit inflammatory responses in"/>
  <result pre="in vivo and help limit the clinical disease associated with" exact="ZIKV" post="infection. That treatment of ZIKV-infected CHME3 microglial cells with"/>
  <result pre="in metabolic activity and reduced percentage of viability due to" exact="ZIKV" post="infection. If similar responses occurred with microglial cells in"/>
  <result pre="microglia could help sustain an effective response fostering eradication of" exact="ZIKV" post="from brain. Finally, since there is only one subtype"/>
  <result pre="hypothesized that iminosugars would cause similar antiviral effects against different" exact="ZIKV" post="isolates. The results of this study were in strong"/>
  <result pre="the addition of castanospermine, celgosivir, and DNJ, regardless of the" exact="ZIKV" post="strain used. These isolates represent strains isolated from 1968"/>
  <result pre="show that celgosivir may be a promising iminosugar to treat" exact="ZIKV" post="and potentially prevent microcephaly. In light of celgosivir’s action"/>
  <result pre="We have shown here three iminosugars that are active against" exact="ZIKV" post="in a dose-dependent manner in vitro. These results are"/>
  <result pre="the possibility that iminosugars may be a promising therapeutic against" exact="ZIKV" post="infections. Data Availability Statement The datasets generated for this"/>
  <result pre="flaviviruses.Curr. Opin. Virol.9134–142. 10.1016/j.coviro.2014.09.02025462445 BhatnagarJ.RabeneckD. B.MartinesR. B.Reagan-SteinerS.ErmiasY.EstetterL. B.et al. (2017)." exact="Zika" post="virus RNA replication and persistence in brain and placental"/>
  <result pre="tissue.Emerg. Infect. Dis.23405–414. 10.3201/eid2303.16149927959260 Cao-LormeauV. M.RocheC.TeissierA.RobinE.BerryA. L.MalletH. P.et al. (2014)." exact="Zika" post="virus, French polynesia, South pacific, 2013.Emerg. Infect. Dis.201085–1086.24856001 CarlinA."/>
  <result pre="al. (2018). Deconvolution of pro- and antiviral genomic responses in" exact="Zika" post="virus-infected and bystander macrophages.Proc. Natl. Acad. Sci. U.S.A.115E9172–E9181. 10.1073/pnas.180769011530206152"/>
  <result pre="(2017). N-Methyl-d-Aspartate (n.d.) receptor blockade prevents neuronal death induced by" exact="Zika" post="Virus infection.mBio8;e350-17. 10.1128/mBio.00350-1728442607 DatemaR.OlofssonS.RomeroP. A. (1987). Inhibitors of protein"/>
  <result pre="in viral systems.Pharmacol. Ther.33221–286. 10.1016/0163-7258(87)90066-03310033 DickG. W.KitchenS. F.HaddowA. J. (1952)." exact="Zika" post="virus. I. isolations and serological specificity.Trans. R. Soc. Trop."/>
  <result pre="A sensitive virus yield assay for evaluation of antivirals against" exact="Zika" post="Virus.J. Virol. Methods23813–20. 10.1016/j.jviromet.2016.09.01527678028 Gomez PerdigueroE.KlapprothK.SchulzC.BuschK.AzzoniE.CrozetL.et al. (2015). Tissue-resident"/>
  <result pre="HaddowA. D.SchuhA. J.YasudaC. Y.KasperM. R.HeangV.HuyR.et al. (2012). Genetic characterization of" exact="Zika" post="virus strains: geographic expansion of the Asian lineage.PLoS Negl."/>
  <result pre="10.1371/journal.pntd.000147722389730 JaegerA. S.MurrietaR. A.GorenL. R.CrooksC. M.MoriartyR. V.WeilerA. M.et al. (2019)." exact="Zika" post="viruses of African and Asian lineages cause fetal harm"/>
  <result pre="Dis.13:e0007343. 10.1371/journal.pntd.000734330995223 KendraM. Q.BowenJ. R.JohnsonE. L.CirceE.McDonaldH. M.O’NealJ. T.et al. (2016)." exact="Zika" post="virus infects human placental macrophages.Cell Host Microbe2083–90. 10.1016/j.chom.2016.05.01527247001 KimM.-J.HwangS.-Y.ImaizumiT.YooJ.-Y."/>
  <result pre="carbohydrate perspective.Pharmaceuticals10:E44. 10.3390/ph1002004428471403 LanciottiR. S.LambertA. J.HolodniyM.SaavedraS.Signor LdelC. (2016). Phylogeny of" exact="Zika" post="Virus in western hemisphere, 2015.Emerg. Infect. Dis.22933–935. 10.3201/eid2205.16006527088323 LimontaD.JovelJ.KumarA.AiroA."/>
  <result pre="10.3201/eid2205.16006527088323 LimontaD.JovelJ.KumarA.AiroA. M.HouS.SaitoL.et al. (2018). Human fetal astrocytes infected with" exact="Zika" post="Virus exhibit delayed apoptosis and resistance to interferon: implications"/>
  <result pre="(2018). Seasonality of birth defects in West Africa: could congenital" exact="Zika" post="syndrome be to blame?F1000Res.7:159. 10.12688/f1000research.13858.230079237 ManangeeswaranM.IrelandD. D.VerthelyiD. (2016). Zika"/>
  <result pre="congenital Zika syndrome be to blame?F1000Res.7:159. 10.12688/f1000research.13858.230079237 ManangeeswaranM.IrelandD. D.VerthelyiD. (2016)." exact="Zika" post="(PRVABC59) infection is associated with T cell Infiltration and"/>
  <result pre="potential broad based anti-viral agents.FEBS Lett.43017–22. 10.1016/s0014-5793(98)00525-09678587 MlakarJ.KorvaM.TulN.PopoviæM.Poljšak-PrijateljM.MrazJ.et al. (2016)." exact="Zika" post="Virus associated with microcephaly.N. Engl. J. Med.374951–958.26862926 MuramatsuD.KawataK.AokiS.UchiyamaH.OkabeM.MiyazakiT.et al."/>
  <result pre="genes in macrophage-like cell lines.Sci. Rep.4:4777. 10.1038/srep0477724759061 MussoD.GublerD. J. (2016)." exact="Zika" post="Virus.Clin. Microbiol. Rev.29487–524. 10.1128/CMR.00072-1527029595 NasirudeenA. M. A.WongH. H.ThienP.XuS.LamK.-P.LiuD. X."/>
  <result pre="and TLR3 Synergistically Play an Important Role in Restriction of" exact="Dengue" post="Virus Infection.PLoS Negl. Trop. Dis.5:e926. 10.1371/journal.pntd.000092621245912 OehlerE.WatrinL.LarreP.ILeparc-GoffartS. L.ValourF.BaudouinL.et al."/>
  <result pre="Virus Infection.PLoS Negl. Trop. Dis.5:e926. 10.1371/journal.pntd.000092621245912 OehlerE.WatrinL.LarreP.ILeparc-GoffartS. L.ValourF.BaudouinL.et al. (2014)." exact="Zika" post="virus infection complicated by Guillain-Barre syndrome–case report, French Polynesia.Euro"/>
  <result pre="24626205 Oliveira MeloA. S.MalingerG.XimenesR.SzejnfeldP. O.Alves SampaioS.Bispo de FilippisA. M. (2016)." exact="Zika" post="virus intrauterine infection causes fetal brain abnormality and microcephaly:"/>
  <result pre="Gynecol.476–7. 10.1002/uog.1583126731034 OlmoI. G.CarvalhoT. G.CostaV. V.Alves-SilvaJ.FerrariC. Z.Izidoro-ToledoT. C.et al. (2017)." exact="Zika" post="virus promotes neuronal cell death in a non-cell autonomous"/>
  <result pre="P.MeurenL. M.CoelhoS. V. A.LucasC. G. D. O.MustafáY. M.LemosF.et al. (2017)." exact="Zika" post="Virus infects, activates, and crosses brain microvascular endothelial cells,"/>
  <result pre="in vivo.Antivir. Res.9835–43. 10.1016/j.antiviral.2013.01.00423376501 PetersenL. R.JamiesonD. J.PowersA. M.HoneinM. A. (2016)." exact="Zika" post="Virus.N. Engl. J. Med.3741552–1563.27028561 QuX.PanX.WeidnerJ.YuW.AlonziD.XuX.et al. (2011). Inhibitors of"/>
  <result pre="development.Front. Hum. Neurosci.10:566. 27877121 RetallackH.Di LulloE.AriasC.KnoppK. A.LaurieM. T.Sandoval-EspinosaC.et al. (2016)." exact="Zika" post="virus cell tropism in the developing human brain and"/>
  <result pre="S.ShimB.-S.KwonY.-C.ZhangR.OtsukaY.SchmittK.et al. (2017). infection of human fetal endothelial cells distinguishes" exact="Zika" post="virus from other pathogenic flaviviruses.Proc. Natl. Acad. Sci. U.S.A.1142024–2029."/>
  <result pre="MartinesJ. B.BhatnagarJ.Kelly KeatingM.Silva-FlanneryL.MuehlenbachsA.GaryJ. (2016). Notes from the field: evidence of" exact="Zika" post="Virus infection in brain and placental tissues from two"/>
  <result pre="Rep.65159–160. 10.15585/mmwr.mm6506e126890059 RussoF. B.Beltrao-BragaP. C. B. (2017). The impact of" exact="Zika" post="virus in the brain.Biochem. Biophys. Res. Commun.492603–607.28108286 SadatM. A.MoirS.ChunT.-W.LussoP.KaplanG.WolfeL.et"/>
  <result pre="J.EzashiT.RobertsR. M.FranzA. W. E. (2018). African and Asian strains of" exact="Zika" post="virus differ in their ability to infect and lyse"/>
  <result pre="F.SampaioG. L. A.PereiraC. S.CamposG. S.SardiS. I.FreitasL. A. R.et al. (2016)." exact="Zika" post="virus infection induces mitosis abnormalities and apoptotic cell death"/>
  <result pre="in dengue fever patients.PLoS Negl. Trop. Dis.10:e0004851. 10.1371/journal.pntd.000485127509020 SwartwoutB.ZlotnickM.SaverA.McKennaC.BertkeA. (2017)." exact="Zika" post="Virus persistently and productively infects primary adult sensory neurons"/>
  <result pre="adult sensory neurons in vitro.Pathogens6:49. 10.3390/pathogens604004929027940 TangH.HammackC.OgdenS. C.WenZ.QianX.LiY.et al. (2016)." exact="Zika" post="Virus Infects Human Cortical Neural Progenitors and Attenuates Their"/>
  <result pre="with aberrant glycoprotein synthesis.Antivir. Res.1011–26. 10.1016/0166-3542(88)90011-32852915 TiwariS. K.DangJ.QinY.LichinchiG.BansalV.RanaT. M. (2017)." exact="Zika" post="virus infection reprograms global transcription of host cells to"/>
  <result pre="Microbes Infect.6e24. 10.1038/emi.2017.928442752 UdenzeD.ITrusN. B.GerdtsV.KarniychukU. (2019). The African strain of" exact="Zika" post="virus causes more severe in utero infection than Asian"/>
  <result pre="a porcine fetal transmission model.Emerg. Microbes Infect.81098–1107. 10.1080/22221751.2019.164496731340725 VorouR. (2016)." exact="Zika" post="virus, vectors, reservoirs, amplifying hosts, and their potential to"/>
  <result pre="of concept clinical trial.Antivir. Res.9632–35. 10.1016/j.antiviral.2012.07.00822867971 WenZ.SongH.MingG.-L. (2017). How does" exact="Zika" post="virus cause microcephaly?Genes Dev.31849–861. 10.1101/gad.298216.11728566536 WhitbyK.PiersonT. C.GeissB.LaneK.EngleM.ZhouY.et al. (2005)."/>
  <result pre="treatment of hepatitis C.Antivir. Chem. Chemother.15141–151. 10.1177/09563202040150030415266896 collab: WHO, (2016)." exact="Zika" post="Virus, Microcephaly and Guillain-Barré syndrome.Geneva: WHO. WuS.-F.LeeC.-J.LiaoC.-L.DwekR. A.ZitzmannN.LinY.-L. (2002)."/>
  <result pre="al. (2017). A single mutation in the prM protein of" exact="Zika" post="virus contributes to fetal microcephaly.Science358933–936. 10.1126/science.aam712028971967 ZakariaM. K.CarlettiT.MarcelloA. (2018)."/>
 </snippets>
</snippetsTree>
